CAMBRIDGE, Mass., Jan. 5, 2011 /PRNewswire/ -- Idenix
Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix
management will present a corporate overview at the upcoming 29th
Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2011 at 3:30 p.m. PT (6:30 p.m.
ET) at the Westin St. Francis in San Francisco.
The live and archived webcast of the company presentation can be
accessed under "Calendar of Events" in the Idenix Investor Center
at www.idenix.com. Please log in approximately 5-10 minutes before
the event to ensure a timely connection. The archived replay will
be available on the Idenix website for two weeks following the
conference.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical company engaged in the discovery and development
of drugs for the treatment of human viral diseases. Idenix's
current focus is on the treatment of patients with chronic
hepatitis C infection. For further information about Idenix, please
refer to www.idenix.com.
|
Idenix Pharmaceuticals
Contact:
|
|
|
Kelly Barry (617) 995-9033
(media)
|
|
|
SOURCE Idenix Pharmaceuticals, Inc.